Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.

Ethosuximide does not demonstrate efficacy over placebo for the treatment of irritable bowel syndrome-related abdominal pain and has limited tolerability.

The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...

Night-time leg cramps are common but poorly understood. An orthopaedic doctor explains why they strike during sleep, what ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

MADISON, Wis. — The Madison Police Department said on Wednesday that it has requested a formal review of the deadly Abundant Life Christian School shooting. Police stated that this request comes with ...

While occasional caffeine consumption can cause a temporary rise in blood pressure, regular, moderate coffee consumption does ...

Update December 29, 2025: Google has added six more free channels to its Freeplay offering. Summary: Google TV’s Freeplay is a group of hundreds of free channels that are streaming 24/7. These are ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...